GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
S

SCI Pharmtech 4119.TW · TWD

Health Care · Taiwan Stock Exchange · 🇹🇼 Taiwan

Compare

50.80

+2.52%

Close of 9 Nov 2026, in TWD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Popular Bitcoin Ethereum Nvidia Apple S&P 500 Gold EUR/USD US 10Y

At a glance

Figures in TWD, from our data supplier.

FY2025

Revenue

TWD 1.34bn

FY2016FY2025

Net income

TWD 107.4m

FY2016FY2025

Free cash flow

−TWD 389.7m

FY2016FY2025

Shareholders' equity

TWD 5.39bn

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
RevenueTWD 1.34bnTWD 1.52bnTWD 1.20bnTWD 899.7mTWD 864.2mTWD 2.69bnTWD 2.36bnTWD 1.94bnTWD 1.30bnTWD 1.90bn
Research and developmentTWD 37.8mTWD 42.7mTWD 49.1mTWD 39.6mTWD 30.3mTWD 43.4mTWD 38.9mTWD 36.9mTWD 33.1mTWD 35.6m
Operating incomeTWD 155.2mTWD 198.3mTWD 163.1mTWD 404.3mTWD 63.3mTWD 469.7mTWD 705.2mTWD 516.7mTWD 234.5mTWD 516.5m
Net incomeTWD 107.4mTWD 534.7mTWD 294.7mTWD 308.8mTWD 55.7mTWD 360.1mTWD 571.1mTWD 447.2mTWD 191.0mTWD 417.0m
Diluted earnings per share0.904.472.472.820.583.785.994.702.004.38

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assetsTWD 6.89bnTWD 7.20bnTWD 6.69bnTWD 4.96bnTWD 4.19bnTWD 4.57bnTWD 4.08bnTWD 3.79bnTWD 3.30bnTWD 3.55bn
Cash and short-term investmentsTWD 74.8mTWD 692.8mTWD 1.03bnTWD 264.4mTWD 692.6mTWD 633.0mTWD 1.02bnTWD 791.3mTWD 670.6mTWD 864.6m
Total liabilitiesTWD 1.49bnTWD 1.72bnTWD 1.59bnTWD 1.33bnTWD 869.3mTWD 1.25bnTWD 606.8mTWD 578.8mTWD 365.9mTWD 479.4m
DebtTWD 942.7mTWD 990.4mTWD 1.04bnTWD 545.4mTWD 2.2mTWD 2.6mTWD 3.0m———
Shareholders' equityTWD 5.39bnTWD 5.48bnTWD 5.10bnTWD 3.63bnTWD 3.32bnTWD 3.32bnTWD 3.47bnTWD 3.21bnTWD 2.93bnTWD 3.07bn
Shares outstanding120m120m120m110m97m95m95m95m96m95m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operationsTWD 220.3mTWD 860.5mTWD 215.8mTWD 296.6mTWD 280.3mTWD 971.5mTWD 791.6mTWD 480.2mTWD 281.7mTWD 502.1m
Capital spending−TWD 610.0m−TWD 946.6m−TWD 1.03bn−TWD 1.17bn−TWD 775.0m−TWD 217.7m−TWD 204.5m−TWD 162.4m−TWD 147.4m−TWD 177.2m
Free cash flow−TWD 389.7m−TWD 86.1m−TWD 813.6m−TWD 871.0m−TWD 494.7mTWD 753.8mTWD 587.1mTWD 317.7mTWD 134.3mTWD 324.9m
Dividends paid−TWD 179.3m−TWD 149.4m−TWD 23.8m—−TWD 39.7m−TWD 461.0m−TWD 333.8m−TWD 170.9m−TWD 333.5m−TWD 304.4m

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
RevenueTWD 272.9mTWD 375.8mTWD 355.5mTWD 256.4mTWD 371.5mTWD 360.3mTWD 401.8mTWD 419.3m
Operating incomeTWD 9.3mTWD 33.2mTWD 42.8mTWD 18.7mTWD 59.4mTWD 34.3mTWD 47.3mTWD 50.9m
Net income−TWD 12.8mTWD 20.1mTWD 38.9mTWD 14.0mTWD 22.8mTWD 31.7mTWD 46.8mTWD 381.1m
Diluted earnings per share-0.110.170.320.120.190.260.393.19
Cash from operationsTWD 156.0mTWD 36.0mTWD 62.0m−TWD 32.0mTWD 84.0mTWD 105.0mTWD 792.0mTWD 55.0m
Capital spending−TWD 60.0m−TWD 107.0m−TWD 98.0m−TWD 131.0m−TWD 125.0m−TWD 254.0m−TWD 515.0m−TWD 213.0m
Free cash flowTWD 96.0m−TWD 71.0m−TWD 36.0m−TWD 163.0m−TWD 41.0m−TWD 149.0mTWD 277.0m−TWD 158.0m
Total assetsTWD 6.93bnTWD 6.95bnTWD 6.89bnTWD 6.85bnTWD 7.01bnTWD 7.08bnTWD 7.20bnTWD 7.23bn
Cash and short-term investmentsTWD 84.1mTWD 53.0mTWD 74.8mTWD 77.7mTWD 358.6mTWD 511.4mTWD 692.8mTWD 543.5m
DebtTWD 444.1mTWD 1.04bnTWD 948.3mTWD 907.7mTWD 844.0mTWD 951.5mTWD 984.0mTWD 1.10bn
Shareholders' equityTWD 5.31bnTWD 5.41bnTWD 5.39bnTWD 5.37bnTWD 5.38bnTWD 5.54bnTWD 5.48bnTWD 5.42bn

Financial ratios

Data as of 12 Oct 2026

FY2025FY2024FY2023FY2022FY2021FY2020
Operating margin11.6%44.4%30.8%44.6%9.2%17.5%
Net margin8.0%35.1%24.5%34.3%6.4%13.4%
Return on equity2.0%9.8%5.8%8.5%1.7%10.8%
Return on assets1.6%7.4%4.4%6.2%1.3%7.9%
Free cash flow yield12.4%27.1%18.7%24.0%19.6%22.4%
Revenue growth-11.8%26.5%33.8%4.1%-67.9%14.2%
Earnings growth-79.9%81.4%-4.6%454.4%-84.5%-36.9%
Current ratio1.05x1.64x3.43x1.35x1.87x1.71x
Debt to equity0.17x0.18x0.20x0.15x-0.01x-0.07x
Equity ratio78.3%76.1%76.2%73.2%79.3%72.7%
Interest coverage31.45x122.04x58.90x374.49x1929.27x10923.53x
R&D as a share of sales2.8%2.8%4.1%4.4%3.5%1.6%
Buybacks as a share of market value-0.4%0.0%-9.1%-13.5%-1.3%0.2%

Growth per year

Compound annual rate

3 years5 years10 years
Revenue14.3%-13.0%-2.9%
Operating income-27.3%-19.9%-9.9%
Net income-29.7%-21.5%-11.7%

Average margins

Over each period

1 year3 years5 years10 years
Operating margin12.3%18.5%17.1%21.7%
Net margin22.4%25.1%19.5%20.5%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Price to earnings54.420.339.330.7129.416.513.511.121.312.9
Price to sales4.37.19.610.68.32.23.32.63.12.8

Dividends and splits

Per share, in the currency the company pays

Paid for 3 years. Last went ex-dividend on 1 Jul 2026.

FY2026FY2025FY2024FY2023FY2021FY2020FY2019FY2018
Paid in the year0.751.501.250.2460.4384.233.0631.568
  • 9-for-8 split · 27 Jul 2023
  • 6-for-5 split · 23 Aug 2021
  • 21-for-20 split · 5 Aug 2014
  • 1.08-for-1 split · 5 Aug 2013
  • 1.076-for-1 split · 4 Aug 2011
  • 1.1-for-1 split · 5 Aug 2010

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.